PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered
Authors:
- Patrick M. HonorePHPatrick M. Honore
- Sebastien RedantSRSebastien Redant
- Pharan DjimafoPDPharan Djimafo
- Sydney BlackmanSBSydney Blackman
- Ibrahim BousbiatIBIbrahim Bousbiat
- Emily PerriensEPEmily Perriens
- Thierry PreseauTPThierry Preseau
- Bogdan Vasile CismasBCBogdan Vasile Cismas
- Keitiane KaeferKKKeitiane Kaefer
- Leonel Barreto GutierrezLGLeonel Barreto Gutierrez
- Sami AnaneSASami Anane
- Andrea GalleraniAGAndrea Gallerani
Open Access
- 7 November 2022
- journal article
- letter
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pancreatic stone protein as a biomarker of sepsisCritical Care, 2022
- Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is notCritical Care, 2020
- Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma SeverityAnnals of Surgery, 2020
- A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations auditCritical Care, 2018
- What a clinician should know about a renal replacement membrane?Journal of Translational Internal Medicine, 2018